Skip to main content
Clinical Trials/CTRI/2022/01/039242
CTRI/2022/01/039242
Not yet recruiting
未知

Retrospective and prospective observational study toevaluate the outcome of patients with metastatic hormone-positivebreast cancer treated with a combination of chemotherapy andendocrine therapyâ??

ot applicable0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Sponsor
ot applicable
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients above 18 yrs who have ER and/or PR positive and HER2 negative metastatic breast cancer and who have received a combination of chemotherapy and endocrine therapy between January
  • 2016 and December 2020\.

Exclusion Criteria

  • Patients who have HER2 positive tumors.

Outcomes

Primary Outcomes

Not specified

Similar Trials